A Natural Model ofLeishmania majorInfection Reveals a Prolonged “Silent” Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity
Top Cited Papers
- 15 July 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 165 (2) , 969-977
- https://doi.org/10.4049/jimmunol.165.2.969
Abstract
A model of Leishmania major infection in C57BL/6 mice has been established that combines two main features of natural transmission: low dose (100 metacyclic promastigotes) and inoculation into a dermal site (the ear dermis). The evolution of the dermal lesion could be dissociated into two distinct phases. The initial “silent” phase, lasting 4–5 wk, favored establishment of the peak load of parasites in the dermis in the absence of lesion formation or any overt histopathologic changes in the site. The second phase corresponds to the development of a lesion associated with an acute infiltration of neutrophils, macrophages, and eosinophils into the dermis and was coincident with the killing of parasites in the site. The onset of immunity/pathology was correlated with the appearance of cells staining for IL-12p40 and IFN-γ in the epidermal compartment, and an expansion of T cells capable of producing IFN-γ in the draining lymph node. Parasite growth was not enhanced over the first 4.5 wk in anti-CD4-treated mice, SCID mice, or C57BL/6 mice deficient in IL-12p40, IFN-γ, CD40 ligand, or inducible NO synthase. These mice all failed to ultimately control infection in the site, but in some cases (anti-CD4 treated, IL-12p40−/−, CD40 ligand−/−, and SCID) high dermal parasite loads were associated with little or no pathology. These results extend to a natural infection model a role for Th1 cells in both acquired resistance and lesion formation, and document the remarkable avoidance of this response during a prolonged phase of parasite amplification in the skin.Keywords
This publication has 58 references indexed in Scilit:
- Characterization of the Local and Systemic Immune Responses in Patients with Cutaneous Leishmaniasis Due toLeishmania majorClinical Immunology, 1999
- Leishmania‐infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cellsEuropean Journal of Immunology, 1996
- CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania majorImmunity, 1996
- Protective Role of CD40 in Leishmania major Infection at Two Distinct Phases of Cell-Mediated ImmunityPublished by Elsevier ,1996
- Response of scid mice to establishment of Leishmania major infectionClinical and Experimental Immunology, 1995
- Antigen-presenting cells in human cutaneous leishmaniasis due to Leishmania majorClinical and Experimental Immunology, 1995
- Infection with Leishmania major induces interleukin-12 production in vivoImmunology Letters, 1994
- Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen‐specific T cellsEuropean Journal of Immunology, 1993
- Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response toLeishmania major, the cause of cutaneous leishmaniasisEuropean Journal of Immunology, 1992
- Cellular Reactions in the Dermal Connective Tissue of the Hamster to Leishmania BrasiliensisThe Journal of Infectious Diseases, 1943